[go: up one dir, main page]

AU2001288460A1 - Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant - Google Patents

Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant

Info

Publication number
AU2001288460A1
AU2001288460A1 AU2001288460A AU8846001A AU2001288460A1 AU 2001288460 A1 AU2001288460 A1 AU 2001288460A1 AU 2001288460 A AU2001288460 A AU 2001288460A AU 8846001 A AU8846001 A AU 8846001A AU 2001288460 A1 AU2001288460 A1 AU 2001288460A1
Authority
AU
Australia
Prior art keywords
antioxidant
donor
compositions
sexual dysfunction
treating sexual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288460A
Inventor
Meir S. Sacks
Knox Van Dyke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24622335&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001288460(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of AU2001288460A1 publication Critical patent/AU2001288460A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Methods for treating sexual dysfunction are disclosed. The methods generally comprise the administration of an NO donor and an antioxidant; the active ingredients can be administered topically to the genitals of the patient. The methods allow for localized NO delivery through topical application of the present compounds, while minimizing, if not preventing, damage associated with peroxynitrite formation. Compositions comprising L-arginine, or a derivative thereof and an antioxidant in a pharmaceutical carrier suitable for application to the genitals is also disclosed.
AU2001288460A 2000-09-01 2001-08-29 Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant Abandoned AU2001288460A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/653,794 2000-09-01
US09/653,794 US7128930B1 (en) 2000-09-01 2000-09-01 Compositions and methods for treating sexual dysfunction
PCT/US2001/026817 WO2002019999A2 (en) 2000-09-01 2001-08-29 Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant

Publications (1)

Publication Number Publication Date
AU2001288460A1 true AU2001288460A1 (en) 2002-03-22

Family

ID=24622335

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288460A Abandoned AU2001288460A1 (en) 2000-09-01 2001-08-29 Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant

Country Status (10)

Country Link
US (1) US7128930B1 (en)
EP (1) EP1317309B1 (en)
JP (1) JP2004511443A (en)
AT (1) ATE299740T1 (en)
AU (1) AU2001288460A1 (en)
CA (1) CA2419404C (en)
DE (1) DE60112102T2 (en)
ES (1) ES2242768T3 (en)
MX (1) MXPA03001798A (en)
WO (1) WO2002019999A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1022860C2 (en) * 2003-03-06 2004-09-07 Concepto Worldwide Ltd Device for stimulating the female sexual organ, packaging and dosing device.
ATE418976T1 (en) * 2005-08-04 2009-01-15 Extarma Ag LIQUID COMPOSITION CONTAINING ARGININE AND ALPHA-LIPOIC ACID TO IMPROVE SEXUAL FUNCTION
US20090197892A1 (en) * 2007-08-21 2009-08-06 Nawaz Ahmad Anhydrous compositions useful for attaining enhanced sexual wellness
WO2011130608A1 (en) * 2010-04-15 2011-10-20 Life Science Enhancement Corporation Methods and compositions for enhancing female sexual arousal and treating female sexual dysfunction
JP2013049670A (en) * 2011-08-04 2013-03-14 Fancl Corp Ascorbic acid preparation
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9241899B2 (en) * 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
DE102013018565A1 (en) 2013-10-28 2015-04-30 Gmbu E.V., Fachsektion Dresden Personal care products and their use
ITMI20132049A1 (en) 2013-12-09 2015-06-10 Multichem S A S Di Gabriele Segall A COMPOSITIONS AND METHODS FOR THE STIMULATION OF THE FEMALE AND MALE SEXUAL RESPONSE
WO2018094377A1 (en) * 2016-11-21 2018-05-24 REV Pharmaceuticals LLC Sexual health enhancement composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242391A (en) 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
GB9214247D0 (en) 1992-07-04 1992-08-19 Stephan Peter M Composition for use as a food or food supplement
JP3204510B2 (en) 1993-04-05 2001-09-04 コンペティティブ テクノロジーズ，インク． Diagnosis and treatment of erectile dysfunction
US5439938A (en) 1993-04-07 1995-08-08 The Johns Hopkins University Treatments for male sexual dysfunction
ES2091724B1 (en) 1995-04-07 1997-06-01 Ropero Wermenlinger Luis NEW POTENTIATING LOTION OF SEXUAL CAPACITY IN MAN, PROCEDURE FOR ITS PREPARATION AND ITS APPLICATIONS.
US5595753A (en) * 1995-04-14 1997-01-21 President And Fellows Of Harvard College Topical formulations and methods for treating hemorrhoidal pain and sphincter and smooth muscle spasm in the gastrointestinal tract
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
US6207713B1 (en) * 1997-09-17 2001-03-27 Eric T. Fossel Topical and oral delivery of arginine to cause beneficial effects
US6071272A (en) 1997-10-28 2000-06-06 Hoffman; Alan S. Method for treating erectile dysfunctionality
US6180133B1 (en) * 1997-11-25 2001-01-30 Watson Pharmaceuticals, Inc. Antioxidant composition for topical/transdermal prevention and treatment of wrinkles
AU3221599A (en) 1998-04-03 1999-10-25 Daily Wellness Company, The Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
US6031002A (en) * 1998-05-01 2000-02-29 Michael Ebert Method for enhancing female sexual response and a composition therefor
AU4699299A (en) 1998-06-26 2000-01-17 Nutracorp Scientific, Inc. Promoting nitric oxide and cyclic gmp activity
US6007824A (en) * 1998-07-09 1999-12-28 Duckett; Melvin J. Natural composition and method for the treatment of sexual dysfunction
US6476037B1 (en) * 2000-03-23 2002-11-05 The Regents Of The University Of California L-arginine and phosphodiesterase (PDE) inhibitor synergism
RU2163805C1 (en) 2000-03-29 2001-03-10 Закрытое Акционерное Общество Научно-Производственный Центр "Борщаговский Химико-Фармацевтический Завод" Agent for treatment of men with sexual dysfunction

Also Published As

Publication number Publication date
WO2002019999A3 (en) 2003-03-27
ES2242768T3 (en) 2005-11-16
EP1317309A2 (en) 2003-06-11
DE60112102T2 (en) 2006-05-24
WO2002019999A2 (en) 2002-03-14
CA2419404A1 (en) 2002-03-14
US7128930B1 (en) 2006-10-31
CA2419404C (en) 2012-10-16
DE60112102D1 (en) 2005-08-25
EP1317309B1 (en) 2005-07-20
JP2004511443A (en) 2004-04-15
MXPA03001798A (en) 2004-11-01
ATE299740T1 (en) 2005-08-15

Similar Documents

Publication Publication Date Title
AU2001288460A1 (en) Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant
EP1283054A4 (en) Drugs for complications of diabetes and neuropathy and utilization thereof
CO5271759A1 (en) FORMULATION IN SOLUTION CONTAINING A MIXTURE OF SOLVENTS
DE69519300D1 (en) STABLE MEDICINAL PRODUCT CONTAINING OXALIPLATINE
GB0021317D0 (en) Transdermal pharmaceutical delivery composition
BR0313575C1 (en) Method for improving the efficacy and / or transdermal transport of topically administered nutrients and nutrients, a vehicle for use in topical or transdermal nutrient or nutrition administration, nutritional composition and use of an effective amount of one or more phosphate derivatives of one or more electron transfer agents along with other excipients
AU2274201A (en) Compounds and compositions for delivering active agents
WO2002018327A3 (en) Guanidinobenzamides as mc4-r agonists
DK1030670T3 (en) Use of vitamin D derivatives to enhance the action of cytotoxic agents
GEP20032967B (en) Indolyl-3-Glyoxylic Acid Derivatives As an Antitumor Agent and Pharmaceutical Composition
MXPA02002895A (en) Topical treatment of streptococcal infections.
WO2001013909A3 (en) Compositions and methods for treating opiate intolerance
EP1138323A3 (en) Resveratrol for the treatment of exfoliative eczema, acne or psoriasis
JP2004507496A5 (en)
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
AU2002215982A1 (en) Topical treatment of mastalgia with arometese inhibitors such as androstendione
WO2001064251A3 (en) Combination chemotherapy
TWI256309B (en) New formulation of mirtazapine
KR920019350A (en) Pharmaceutical Compositions for Autoimmune Disease Therapy
TW200503709A (en) Itching treating agent containing piperidine derivative as active ingredient
GEP20043231B (en) Resorcinol Composition
AU2337900A (en) Preparation for warts
CA2361081A1 (en) Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
SE9800905L (en) New therapy with glomerulonephritis